EUVIMEDEUVIMED entdecken
Systematische Übersicht

A systematic review of oncological outcomes after nipple‐sparing mastectomy for breast cancer

Alexandra M Zaborowski, Simon Roe, Jane Rothwell, Denis Evoy, James Geraghty, Damian McCartan, Ruth S Prichard

Journal of Surgical Oncology · 2023-03 · 127 (3) · 361-368

DOI: 10.1002/jso.27115 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Surgical Oncology, online erschienen am 08.10.2022. Verfasst von Alexandra M Zaborowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Endocrine Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Subcutaneous, Carcinoma, Intraductal, Noninfiltrating, Mammaplasty. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nipple‐sparing mastectomy is an alternative to skin‐sparing mastectomy in select patients. Increasing evidence supports its use in the setting of breast cancer, however concerns still exist regarding oncological safety. The aim of this systematic review was to evaluate long‐term oncological outcomes of patients who underwent nipple‐sparing mastectomy for breast cancer. A systematic review of the literature was performed to evaluate oncological outcomes in patients with breast cancer who underwent nipple‐sparing mastectomy. Five major databases (PubMed, Embase, Scopus, Web of Science and Cochrane) were searched. The review included all original articles published in English reporting long‐term oncological outcomes. 2334 studies were identified. After applying inclusion and exclusion criteria, 17 retrospective studies involving 7107 patients were included. The indication for nipple‐sparing mastectomy was invasive carcinoma in 6069 patients (85.4%) and in situ disease in 1038 (14.6%). Median follow up was 48 months (range 25–94). The weighted mean rates of local recurrence and recurrence involving the nipple‐areola complex were 5.4% (0.9–11.9) and 1.3% (0–4.9), respectively. The weighted mean distant failure rate was 4.8% (1.5–23.0). Therapeutic nipple‐sparing mastectomy is oncologically safe in select patients with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomy, SubcutaneousCarcinoma, Intraductal, NoninfiltratingMammaplastyHumansFemaleMastectomyNipplesRetrospective StudiesNeoplasm Recurrence, Local

Stichwörter der Autor:innen

NSMnipple-sparing mastectomyskin-sparing mastectomy

Autor:innen und Institutionen

  • Department of Breast and Endocrine Surgery, St. Vincent's University Hospital, Elm Park, Dublin, Ireland.

Zitieren

APA

Zaborowski, A. M., Roe, S., Rothwell, J., Evoy, D., Geraghty, J., McCartan, D., & Prichard, R. S. (2023). A systematic review of oncological outcomes after nipple‐sparing mastectomy for breast cancer. Journal of Surgical Oncology, 127(3), 361-368. https://doi.org/10.1002/jso.27115

Vancouver

Zaborowski AM, Roe S, Rothwell J, Evoy D, Geraghty J, McCartan D, et al. A systematic review of oncological outcomes after nipple‐sparing mastectomy for breast cancer. Journal of Surgical Oncology. 2023;127(3):361-368. doi:10.1002/jso.27115

BibTeX
@article{Zaborowski2023,
  author = {Zaborowski, Alexandra M and Roe, Simon and Rothwell, Jane and Evoy, Denis and Geraghty, James and McCartan, Damian and Prichard, Ruth S},
  title = {A systematic review of oncological outcomes after nipple‐sparing mastectomy for breast cancer},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {127},
  number = {3},
  pages = {361--368},
  doi = {10.1002/jso.27115}
}
Kostenlos starten →